Seong Jin Kim, PhD

Gilo Foundation and Medpacto Inc.
Seoul, South Korea

Director and CEO

Presentation(s):

• 1731: A Competitive Inhibitor of MOART Showed Potent Therapeutic Effects in a Mouse Model of Collagen-induced Arthritis

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.